skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 61  for All Library Resources

Results 1 2 3 4 next page
Refined by: Database: Coronavirus Research Database remove Journal Title: The Lancet remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Material Type:
Article
Add to My Research

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet, 2020-10, Vol.396 (10259), p.1345-1352 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license ;Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. This work is published under https://creativecommons.org/licenses/by/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32013-4 ;PMID: 33031764

Digital Resources/Online E-Resources

2
COVID-19 and readjusting clinical trials
Material Type:
Article
Add to My Research

COVID-19 and readjusting clinical trials

The Lancet, 2020-08, Vol.396 (10250), p.523-524 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31787-6 ;PMID: 32828180

Digital Resources/Online E-Resources

3
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment
Material Type:
Article
Add to My Research

First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment

The Lancet, 2020-04, Vol.395 (10233), p.1382-1393 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30746-7 ;PMID: 32277878

Digital Resources/Online E-Resources

4
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
Material Type:
Article
Add to My Research

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study

The Lancet, 2020-02, Vol.395 (10225), p.689-697 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30260-9 ;PMID: 32014114

Digital Resources/Online E-Resources

5
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study
Material Type:
Article
Add to My Research

An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study

The Lancet, 2020-06, Vol.395 (10239), p.1771-1778 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31103-X ;PMID: 32410760

Digital Resources/Online E-Resources

6
Scientists are sprinting to outpace the novel coronavirus
Material Type:
Article
Add to My Research

Scientists are sprinting to outpace the novel coronavirus

The Lancet, 2020-03, Vol.395 (10226), p.762-764 [Peer Reviewed Journal]

2020 World Health Organization. Published by Elsevier Ltd. All rights reserved. ;2020. World Health Organization. Published by Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 World Health Organization. Published by Elsevier Ltd. All rights reserved. 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30420-7 ;PMID: 32105610

Digital Resources/Online E-Resources

7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Material Type:
Article
Add to My Research

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

The Lancet, 2020-02, Vol.395 (10223), p.497-506 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30183-5 ;PMID: 31986264

Digital Resources/Online E-Resources

8
COVID-19: consider cytokine storm syndromes and immunosuppression
Material Type:
Article
Add to My Research

COVID-19: consider cytokine storm syndromes and immunosuppression

The Lancet, 2020-03, Vol.395 (10229), p.1033-1034 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30628-0 ;PMID: 32192578

Digital Resources/Online E-Resources

9
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Material Type:
Article
Add to My Research

SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates

The Lancet, 2020-11, Vol.396 (10262), p.1595-1606 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)32137-1 ;PMID: 33065034

Digital Resources/Online E-Resources

10
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Material Type:
Article
Add to My Research

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

The Lancet, 2020-05, Vol.395 (10236), p.1569-1578 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31022-9 ;PMID: 32423584

Digital Resources/Online E-Resources

11
A history of the medical mask and the rise of throwaway culture
Material Type:
Article
Add to My Research

A history of the medical mask and the rise of throwaway culture

The Lancet, 2020-07, Vol.396 (10243), p.19-20 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31207-1 ;PMID: 32450110

Digital Resources/Online E-Resources

12
Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
Material Type:
Article
Add to My Research

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed

The Lancet, 2020-05, Vol.395 (10234), p.1407-1409 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30858-8 ;PMID: 32278362

Digital Resources/Online E-Resources

13
COVID-19: a need for real-time monitoring of weekly excess deaths
Material Type:
Article
Add to My Research

COVID-19: a need for real-time monitoring of weekly excess deaths

The Lancet, 2020-05, Vol.395 (10234), p.e81-e81 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30933-8 ;PMID: 32333839

Digital Resources/Online E-Resources

14
COVID-19: towards controlling of a pandemic
Material Type:
Article
Add to My Research

COVID-19: towards controlling of a pandemic

The Lancet, 2020-03, Vol.395 (10229), p.1015-1018 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30673-5 ;PMID: 32197103

Digital Resources/Online E-Resources

15
COVID-19's impact on Australia's health research workforce
Material Type:
Article
Add to My Research

COVID-19's impact on Australia's health research workforce

The Lancet, 2020-08, Vol.396 (10249), p.461-461 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31533-6 ;PMID: 32798480

Digital Resources/Online E-Resources

16
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Material Type:
Article
Add to My Research

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

The Lancet, 2020-03, Vol.395 (10229), p.1054-1062 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30566-3 ;PMID: 32171076

Digital Resources/Online E-Resources

17
Interference in scientific research on COVID-19 in Turkey
Material Type:
Article
Add to My Research

Interference in scientific research on COVID-19 in Turkey

The Lancet, 2020-08, Vol.396 (10249), p.463-464 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31691-3 ;PMID: 32798483

Digital Resources/Online E-Resources

18
Physical distancing, face masks, and eye protection for prevention of COVID-19
Material Type:
Article
Add to My Research

Physical distancing, face masks, and eye protection for prevention of COVID-19

The Lancet, 2020-06, Vol.395 (10242), p.1950-1951 [Peer Reviewed Journal]

2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by-nc-nd/4.0 ;2020. The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license. This work is published under http://creativecommons.org/licenses/by-nc-nd/3.0/ (theLicense”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license 2020 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31183-1 ;PMID: 32497511

Digital Resources/Online E-Resources

19
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
Material Type:
Article
Add to My Research

Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study

The Lancet, 2020-08, Vol.396 (10251), p.603-611 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31757-8 ;PMID: 32822564

Digital Resources/Online E-Resources

20
What policy makers need to know about COVID-19 protective immunity
Material Type:
Article
Add to My Research

What policy makers need to know about COVID-19 protective immunity

The Lancet, 2020-05, Vol.395 (10236), p.1527-1529 [Peer Reviewed Journal]

2020 Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30985-5 ;PMID: 32353328

Digital Resources/Online E-Resources

Results 1 - 20 of 61  for All Library Resources

Results 1 2 3 4 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To

Searching Remote Databases, Please Wait